Detalhe da pesquisa
1.
Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response.
Hepatology
; 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37729391
2.
Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS).
Cancers (Basel)
; 15(21)2023 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958356
3.
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Mol Cancer Ther
; 22(4): 485-498, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780225
4.
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma.
Cancers (Basel)
; 14(17)2022 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077733
5.
LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways.
Liver Cancer
; 11(2): 126-140, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634422
6.
MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines.
Cell Rep
; 39(12): 110988, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732123